Finance
Pharma company reports first quarter financial results
Published in Women's Health Weekly, May 26th, 2005
"Noven's strategy is to build upon our base hormone therapy (HT) business by introducing our patented transdermal technology into diverse therapeutic categories through collaborations with strong industry partners," said Robert C. Strauss, Noven's president, CEO and chairman. "With continued strong prescription demand for our Vivelle-Dot estrogen patch, and progress made toward commercialization of our partnered fentanyl and methylphenidate products, we are off to a good start in 2005."
Noven's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cardiovascular Disease
Stress due to work, family related to highest risk, worst prognosis in women - Colorectal Cancer
B vitamin intake and plasma levels may be associated with lower risk in women - Comorbidities
Diabetes appears to rob women of usual advantage in heart disease risk - Obstetrics
Routine use of episiotomy offers no benefits to women - Ovarian Cancer
Blocking COX-1 slows tumor growth in mice - Addiction Medicine
Coping skills may aid women being physically abused by alcoholic partner - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
